Cypress acted as financial advisor for the selling of 87,5% of Centro Radioterápico’s shares to Oncotech

M&A

Compartilhe em:

Centro Radioterápico sold 87,5% of its shares to Oncotech

Cypress advised Feedz on the sale of its shares to TOTVS

Cypress advised Braskem S.A. on the purchase of 61.1% of Wise’s shares

Cypress advised CostDrivers on the sale of 100% of its shares to GEP

Cypress advised Zilor on a fundraising operation of R$100 million through the BNDES Renova Bio loan program

Toda comunicação através de rede mundial de computadores está sujeita a interrupções ou atrasos, podendo impedir ou prejudicar o envio de ordens ou a recepção de informações atualizadas. A GALAPAGOS CYPRESS S.A. exime-se de responsabilidade por danos sofridos por seus clientes, por força de falha de serviços disponibilizados por terceiros. A GALAPAGOS CYPRESS S.A. é instituição autorizada a funcionar pelo Banco Central do Brasil e CVM.

Cypress acted as financial advisor for the selling of 87,5% of Centro Radioterápico’s shares to Oncotech

Leia também

Cypress advised Feedz on the sale of its shares to TOTVS

Cypress advised Braskem S.A. on the purchase of 61.1% of Wise’s shares

Cypress advised CostDrivers on the sale of 100% of its shares to GEP

Cypress advised Zilor on a fundraising operation of R$100 million through the BNDES Renova Bio loan program